Compare Citius Pharmaceuticals Inc (CTXR) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Royal Bank of Canada — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while Royal Bank of Canada trades at $215.06 (market cap $291.56B). The key difference: Royal Bank of Canada is far larger — about 19660.1× Citius Pharmaceuticals Inc's market cap, and Royal Bank of Canada pays a 2.42% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | RY | |
|---|---|---|
Market Cap | $14.83M | $291.56B |
Sector | Health | Financials |
52-Week High | $1.82 | $214.04 |
52-Week Low | $0.53 | $128.46 |
Enterprise Value | $11.05M | — |
Dividend Yield | — | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
